Gain Therapeutics, Inc (GANX) insider trading
Every open-market stock purchase and sale by Gain Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Khalid Islam (Chair), $49.9K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.29 on Oct 22, 2026.
Recent GANX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 15, 2026 | Dov A Goldstein Md (Director) | Bought (not open market) | — |
| Jul 15, 2026 | Claude Nicaise (Director) | Bought (not open market) | — |
| Jul 15, 2026 | Khalid Islam (Director) | Bought (not open market) | — |
| Jul 15, 2026 | Gwen A Melincoff (Director) | Bought (not open market) | — |
| Jul 15, 2026 | Jeffrey Scott Riley (Director) | Bought (not open market) | — |
| Jul 15, 2026 | Hans Peter Hasler (Director) | Bought (not open market) | — |
| Mar 24, 2026 | Gianluca Fuggetta (Officer) | Bought (not open market) | — |
| Mar 24, 2026 | Gene Mack (CEO) | Bought (not open market) | — |
Who's trading GANX
- Gwen A Melincoff, Director: other filings, last Jul 15, 2026
- Claude Nicaise, Director: other filings, last Jul 15, 2026
- Dov A Goldstein Md, Director: other filings, last Jul 15, 2026
- Hans Peter Hasler, Director: other filings, last Jul 15, 2026
- Khalid Islam, Director: other filings, last Jul 15, 2026
- Jeffrey Scott Riley, Director: other filings, last Jul 15, 2026
- Gene Mack, CEO: other filings, last Mar 24, 2026
- Gianluca Fuggetta, Officer: other filings, last Mar 24, 2026
Get free alerts when an insider at Gain Therapeutics, Inc files a new trade →